ATOPIC
Clinical trials for ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ATOPIC trials appear
Sign up with your email to follow new studies for ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called camoteskimab in 62 adults with moderate to severe eczema (atopic dermatitis). The goal was to see if it could reduce skin redness, itching, and rash better than a placebo over 12 weeks. Participants received either the drug or a placebo, an…
Matched conditions: ATOPIC
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New eczema drug for kids shows promise in itch relief
Symptom relief CompletedThis study tested a new medicine called TAU-284 in 303 children aged 7 to 15 with atopic dermatitis (eczema). The goal was to see if it could reduce itching better than an existing drug, ketotifen fumarate. Children took the medicine and reported their itch levels over time.
Matched conditions: ATOPIC
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 26, 2026 11:09 UTC